AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis (Review)

International Journal of Oncology

Volumn 12, Issue 3, 1998, Pages 685-700

  Liebermann, Dan A ^a   Gregory, Bernard ^a   Huffman, Barbara ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Differentiation; Fos; Hematopoiesis; Jun

Indexed keywords

TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA DAMAGE; ERYTHROID CELL; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; MACROPHAGE; MAST CELL; MEGAKARYOCYTE; MONOCYTE; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; GENES, FOS; GENES, JUN; HEMATOPOIETIC STEM CELLS; HUMANS; MAMMALS; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1;

EID: 0031908748     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (178)

1. Metcalf D: The molecular control of cell division, differentiation commitment and maturation in hematopoietic cells. Nature 339: 27-30, 1989.
2. Quensbery PJ: Hematopoietic stem cells, progenitor cells, and cytokines. In: Williams Hematology. Beutler E, Lichtman MA, Coller BS and Thomas JK (eds). McGraw-Hill Publ. Co, New York, Chap 22, pp211-229, 1994.
3. Sachs L: The molecular control of blood cell development. Science 238: 1374-1379, 1987.
4. Liebermann DA and Hoffman B: Genetic programs of myeloid cell differentiation. Curr Opin Hematol 1: 24-32, 1994.
5. Squier MK, Sehnert AJ and Cohen JJ: Apoptosis in leukocytes. J Leukoc Biol 57: 2-10, 1995.
6. Shivdasani RA and Orkin SH: The transcriptional control of hematopoiesis. Blood 87: 4025-4039, 1996.
7. Piechaczyk M and Blanchard JM: c-fos proto-oncogene regulation and function. Critic Rev Oncol Hematol 17: 93-131, 1994.
8. Angel P and Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991.
9. Lord KA, Abdollahi A, Hoffman-Liebermann B and Liebermann D: Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol 13: 841-851, 1993.
10. Su B and Karin M: Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8: 402-411, 1996.
11. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486, 1995.
12. Rosette C and Karin M: Ultraviolet light and osmotic stress-activation of the JNK cacsade. Science 274: 1194-1197, 1996.
13. Liu ZG, Hsu HL, Goeddel DV and Karin M: Dissection of the TNF receptor 1 effector functions -JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87: 565-576, 1996.
14. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B and Davis RJ: MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247-1255, 1996.
15. Deng T and Karin M: c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371: 171-175, 1994.
16. Lau LF and Nathans D: Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 84: 1182-1186, 1987.
17. Lau LF and Nathans D: Genes induced by serum growth factors. In: Molecular Aspects of Cellular Regulation. Vol. 6. Cohen P and Foulkes JG (eds). Elsvier, Amsterdam, 1991.
18. Fomace AJ Jr: Mammalian genes induced by radiation; activation of genes associated with growth control. Annu Rev Genet 26: 507-526, 1992.
19. Friedberg C, Walker GC and Siede W (eds): Regulatory response to DNA-damaging agents in eukaryotic cells: gene activation following exposure to DNA-damaging agents. In: DNA Repair and Mutagenesis. ASM Press, pp595-607, 1995.
20. Herrlich P and Rahmsdorf HJ: Transcriptional and post-transcriptional responses to DNA-damaging agents. Curr Opin Cell Biol 6: 425-431, 1994.
21. Herrlich P, Sachsenmaier C, Radler-Pohl A, Gebel S, Blattner C and Rahmsdorf HJ: The mammalian UV response: mechanism of DNA damage induced gene expression. Adv Enzyme Regul 34: 381-395, 1994.
22. Weichselbaum RR, Hallahan D, Fuks Z and Kufe D: Radiation induction of immediate early genes: effectors of the radiation-stress response. Int J Radiat Oncol Biol Phys 30: 229-234, 1994.
23. Bravo R: Genes induced during the G0/G1 transition in mouse fibroblasts. Semin Cancer Biol 1: 7-46, 1990.
24. Distel RJ and Spiegelman BM: Protooncogene c-fos as a transcription factor. Adv Cancer Res 55: 37-55, 1990.
25. Panterne B, Hatzfeld J, Blanchard JM, Levesque JP, Berthier R, Ginsbourg M and Hatzfeld A: c-fos mRNA constitutive expression by mature human megakaryocytes. Oncogene 7: 2341-2344, 1992.
26. Kreipe H, Radzun HJ, Heidom K, Parwaresch MR and Verrier B: Muller R Lineage-specific expression of c-fos and c-fins in human hematopoietic cells: discrepancies with the in vitro differentiation of leukemia cells. Differentiation 33: 56-60, 1986.
27. Selvakumaran M, Liebermann D and Hoffman-Liebermann B: Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis. Blood 81: 2257-2262, 1993.
28. Lord KA, Abdollahi A, Thomas SM, DeMarco M, Brugge JS, Hoffman-Liebermann B and Liebermann D: Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response including tyrosine phosphorylation upon induction of myeloid leukemia differentiation. Mol Cell Biol 11: 4371-4379, 1991.
29. Hoffman B and Liebermann DA: Molecular controls of apoptosis: differentiation/growth arrest primary response genes, protooncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene 9: 1807-1812, 1994.
30. Liebermann DA and Huffman B: Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Stem Cells 12: 352-369, 1994.
31. Selvakumaran M, Liebermann DA and Hoffman-Liebermann B: Deregulated c-myb disrupts IL6/LIF induced myeloid differentiation prior to c-myb: role in leukemogenesis. Mol Cell Biol 12: 2493-2500, 1992.
32. Lord KA, Hoffman-Liebermann B and Liebermann D: Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants. Oncogene 5: 387-396, 1990.
33. Lord KA, Abdollahi A, Hoffman-Liebermann B and Liebermann D: Dissection of the immediate early response of myeloid cells to terminal differentiation and growth inhibitory stimuli. Cell Growth Differ 1: 637-645, 1990.
34. Liebermann D and Hoffman-Liebermann B: Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene 4: 583-592, 1989.
35. Ray A, Sassone-Corsi P and Sehgal PB: A multiple cytokine-and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol Cell Biol 9:5537-5547, 1989.
36. Tanabe O, Akira S, Kamiya T, Wong GG, Hirano T and Kishimito T: Genomic structure of the murine IL6 gene. J Immunol 141: 3875-3881, 1988.
37. Lopez-Rodriguez C, Kluin-Nelemans HC and Corbi AL: AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene. J Immunol 156: 3780-3787, 1996.
38. Aragones J, Lopez-Rodriguez C, Corbi AL, del Arco PG, Lopez-Cabrera M, de Landazuri MO and Redondo JM: Dithiocarbamates trigger differentiation and induction of CD11c gene through AP-1 in the myeloid lineage. J Biol Chem 271: 10924-10931, 1996.
39. Seimiya H, Sawabe T, Toho M and Tsuruo T: Phorbol esterresistant monoblastoid leukemia cells with a functional mitogen-activated protein kinase cascade but without responsive protein tyrosine phosphatases. Oncogene 11: 2047-2054, 1994.
40. Tonetti DA, Horio M, Collart FR and Huberman E: Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation. Cell Growth Differ 3: 739-745, 1992.
41. Hambleton J, Weinstein SL, Lem L and Defranco AL: Activation of c-Jun terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 93: 2774-2778, 1996.
42. Roussel MF: Signal transduction by the macrophage-colony-stimulating factor receptor (CSF-1R). J Cell Science 18 (Suppl.): 105-108, 1994.
43. Momiyama N, Shimada H and Mitsuhashi M: Suppression of c-jun by antisense oligonucleotides inhibits cell adhesion but not respiratory burst during phorbol ester-induced differentiation of U937 human monoblastic cells. Cell Growth Differ 7: 1005-1012, 1996.
44. Patel HR and Sytkowski AJ: Erythropoietin activation of API (Fos/Jun). Exp Hematol 23: 619-625, 1995.
45. Adunyah SE, Ceesay KJ and Rivero JA: Regulation of jun expression and activation of AP-1 activity by erythropoietin. Biochem Biophys Res Commun 221: 213-218, 1996.
46. Grigoriadis AE, Wang ZQ and Wagner EF: Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet 11: 436-441, 1995.
47. Wang, ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U and Wagner EF: Bone and haematopoietic defects in mice lacking c-fos. Nature 360: 741-745, 1992.
48. Johnson RS, Spiegelman BM and Papaioannou V: Pleiotropic, effects of a null mutation in the c-fos proto-oncogene. Cell 71: 577-586, 1992.
49. Marks SC: Osteoclast biology: lessons from mammalian mutations. Am J Med Genet 34: 43-54, 1989.
50. Montgomery C, Geske R and Bradley A: Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702, 1991.
51. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed-Ansari A, Sell KW, Pollard JW and Stanley ER: Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 87: 4828-4832, 1990.
52. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD and Nishikawa S: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444, 1990.
53. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA and Wagner EF: c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448, 1994.
54. Ruther U, Komitowski D, Schubert FR and Wagner EF: c-fos expression induces bone tumors in transgenic mice. Oncogene 4: 861-865, 1989.
55. Barton K, Muthusamy N, Chanyangam M, Fischer C, Clendenin C and Leiden JM: Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 379: 81-85, 1996.
56. Jain J, Nalefski EA, McCaffrey PG, Johnson RS, Spiegelman BM, Papaioannou V and Rao A: Normal peripheral T-cell function in c-Fos-deficient mice. Mol Cell Biol 14: 1566-1574, 1994.
57. Fujita K, Imoto S, Phuchareon J and Tokuhisa T: c-fos and jun gene expression in murine precursor B lymphocytes developed in the interleukin-7-dependent bone marrow cell culture. Immunobiology 190: 13-22, 1994.
58. Okada S, Wang ZQ, Grigoriadis AE, Wagner EF and von Ruden T: Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol Cell Biol 14: 382-390, 1994.
59. Gu H, Marth JD, Orban PC, Mossmann H and Rajewsky K: Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265: 103-106, 1994.
60. Raff MC: Social controls on cell survival and cell death. Nature 356: 397-400, 1992.
61. Ellis RE, Yuan J and Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663-698, 1991.
62. Wyllie AH, Kerr JRR and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-307, 1980.
63. Oppenheim RW: Cell death during development of the nervous system. Ann Rev Neurosci 14: 453-501, 1991.
64. Cohen JJ: Programmed cell death in the immune sytem. Adv Immunol 50: 55-85, 1991.
65. Chen CY, Lee MH, Kastan MB and Canman CE: DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis. Cold Spring Harb Symp Quant Biol 59: 277-286, 1994.
66. Dewey WC, Ling CC and Meyn RE: Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33: 781-796, 1995.
67. Eastmann A: Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2: 275-280, 1990.
68. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994.
69. Powell SN and Abraham EH: The biology of radioresistance: similarities, differences and interactions with drug resistance. Cytotechnology 12: 325-345, 1993.
70. Arends MJ and Wyllie AH: Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 32: 223-254, 1991.
71. Hickman JA, Potten CS, Merritt AJ and Fisher TCI: Apoptosis and cancer chemotherapy. Philos Trans R Soc Lond B Biol Sci 345: 319-325, 1994.
72. Wyllie AH: The biology of cell death in tumours. Anticancer Res 5: 131-136, 1985.
73. Reed JC: Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 7: 541-556, 1995.
74. Thompson CB: Apoptosis in the patogenesis of treatment diesease. Science 267: 1456-1462, 1995.
75. Bellamy CO, Malcomson RD, Harrison DJ and Wyllie AH: Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol 6: 3-16, 1995.
76. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097-1098, 1991.
77. Nagata S and Golstein P: The fas death factor. Science 267: 1449-1456, 1995.
78. Smith CA, Farrah T and Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962, 1994.
79. Ruscetti F, Varesio L, Ochoa A and Ortaldo J: Pleiotropic effects of TGF-beta on cells of the immune system. Ann NY Acad Sci 685: 488-500, 1993.
80. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W and Schulte-Hermann R: Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 89: 5408-5412, 1992.
81. Rotello RJ, Lieberman RC, Purchio AF and Gerschenson LE: Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 88: 3412-3415, 1991.
82. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980.
83. Eastman A and Barry MA: The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? Cancer Invest 10: 229-240, 1992.
84. Martin SJ, Green DR and Cotter TG: Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem Sci 1: 26-30, 1994.
85. Farber E: Programmed cell death: necrosis versus apoptosis. Mod Pathol 7: 605-609, 1994.
86. McConkey DJ and Orrenius S: Calcium and cyclosporin A in the regulation of apoptosis. Curr Top Microbiol Immunol 200: 95-105, 1995.
87. Sunderman FW Jr: The influence of zinc on apoptosis. Annal Clin Lab Sci 25: 134-142, 1995.
88. Lucas M and Sanchez-Margalet V: Protein kinase C involvement in apoptosis. Gen Pharmacol 26: 881-887, 1995.
89. Obeid LM and Hannun YA: Ceramide: a stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 58: 191-198, 1995.
90. Gajewski TF and Thompson CB: Apoptosis meets signal transduction-elimination of a BAD influence. Cell 87: 589-592, 1996.
91. L. Cell 87: 619-628, 1996.
92. Wang HG, Rapp UR and Reed JC: Bcl-2 targets the protein kinase raf-1 to mitochondria. Cell 87: 629-638, 1996.
93. Yang E and Korsmeyer SJ: Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386-401, 1996.
94. Fraser A and Evan GA: License to kill. Cell 85: 781-784, 1996.
95. Martin SJ and Green DR: Protease activation during apoptosis: death by a thousand cuts? Cell 82: 349-352, 1995.
96. Oltavi ZN and Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 79: 189-192, 1994.
97. Liebermann DA, Hoffman B and Steinmann RA: Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11: 199-210, 1995.
98. Packham G and Cleveland JL: c-Myc and apoptosis. Biochim Biophys Acta 1242: 11-28, 1995.
99. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888, 1991.
100. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879-886, 1992.
101. Boise LH, Gonzalez-Garcia M, Postema CR, Ding L, Lindsten T, Turka LA, Mao Z, Nunez G and Thompson CB: bcl-X, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993.
102. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74: 609-619, 1993.
103. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI and Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736, 1995.
104. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C and Brown R: Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374: 731-733, 1995.
105. Gottschalk AR, Boise LH, Thompson CB and Quintans J: Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-X but not bcl-2. Proc Natl Acad Sci USA 91: 7350-7354, 1994.
106. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H and Tsujimoto Y: Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-XL. Nature 374: 811-813, 1995.
107. Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ: Bad, a heterodimeric partner for Bel-XL and Bcl-2, displaces bax and promotes cell death. Cell 80: 285-291, 1995.
108. Miura M, Zhu H, Rotello R, Hrtweig, EA and Yuan J: Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660, 1993.
109. Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G and Clarke MF: Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol 13: 711-719, 1993.
110. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M: Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
111. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Huffman B and Liebermann DA: Immediate early up-regulation of bax expression by p53 but not TGFβ1: a paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798, 1994.
112. Liu ZG, Baskaran R, Leachou ET, Wood LD, Chen Y, Karin M and Wang JYJ: Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384: 273-276, 1996.
113. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebermann DA, Huffman B and Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994.
114. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128, 1992.
115. Askew DS, Ashmun RA, Simmons BC and Cleveland JL: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922, 1991.
116. Selvakumaran M, Lin HK, Tjin Tham Sjin R, Reed J, Liebermann D and Hoffman B: The novel primary response gene MyD118 and the proto-oncogenes myb, myc and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14: 2352-2360, 1994.
117. Wagner AJ, Kokontis JM and Hay N: Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21/waf1/cip1. Genes Dev 8: 2817-2830, 1994.
118. Hermeking H and Eick D: Mediation of c-myc-induced apoptosis by p53. Science 265: 2091-2093, 1994.
119. Bissonnette RP, Echeverri F, Mahboubi A and Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554, 1992.
120. Superti-Furga G, Bergers G, Picard D and Busslinger M: Hormone-dependent transcriptional regulation and cellular transformation by fos-steroid receptor fusion proteins. Proc Natl Acad Sci USA 88: 5114-5118, 1991.
121. Smeyne RJ, Schilling K, Robertson L, Luk D, Oberdick J, Curran T and Morgan JI: Fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron 8: 13-23, 1992.
122. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T and Morgan JI: Continuous c-fos expression precedes programmed cell death in vivo. Nature 363: 166-169, 1993.
123. McCabe LR, Kockx M, Lian J, Stein J and Stein G: Selective expression of fos- and Jun-related genes during osteoblast proliferation and differentiation. Exp Cell Res 218: 255-262, 1995.
124. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F and Jaggi R: Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 9: 1213-1223, 1994.
125. Buttyan R, Zakeri Z, Lockshin R and Wolgemuth D: Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 2: 650-657, 1988.
126. Roffler-Tarlov S, Brown JJ, Tarlov E, Stolarov J, Chapman DL, Alexiou M and Papaioannou VE: Programmed cell death in the absence of c-Fos and c-Jun. Development 122: 1-9, 1996.
127. Colotta F, Polentarutti N, Sironi M and Mantovani A: Expression and involvment of c-fos and c-jun proto-oncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267: 18278-18283, 1992.
128. Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R and Johnson EM Jr: Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127: 1717-1727, 1994.
129. Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M and Rubin LL: A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927-939, 1995.
130. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.
131. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
132. Heidenreich KA and Kummer JL: Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 271: 9891-9894, 1996.
133. Bogoyevitch MA, Ketterman AJ and Sugden PH: Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 270: 29710-29717, 1995.
134. Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA and Barrett JC: Induction of apoptosis by c-Fos protein. Mol Cell Biol 16: 211-218, 1996.
135. Caelles C, Helmberg A and Karin M: p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-223, 1994.
136. Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M: Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev 9: 2170-2183, 1996.
137. Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins JR and May E: Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene 11: 2197-2205, 1995.
138. Holbrook NJ and Fornace AJ Jr: Response to adversity: molecular control of gene activation following genotoxic stress. New Biol 3: 825-833, 1991.
139. Schreiber M, Baumann B, Gotten M, Angel P and Wagner EF: Fos is an essential component of the mammalian UV response. EMBO J 14: 5338-5349, 1995.
140. Johnson NL, Gardner AM, Diener KM, Lange-Carter CA, Gleavy J, Jarpe MB, Minden A, Karin M, Zon LI and Johnson GL: Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 271: 3229-3237, 1996.
141. Gillardon F, Eschenfelder C, Uhlmann E, Hartschuh W and Zimmermann M: Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion. Oncogene 9: 3219-3225, 1994.
142. Hallahan DE, Dunphy E, Virudachalam S, Sukhatme VP, Kufe DW and Weichselbaum RR: C-jun and Egr-1 participate in DNA synthesis and cell survival in response to ionizing radiation exposure. J Biol Chem 270: 30303-30309, 1995.
143. Devary Y, Gottlieb RA, Smeal T and Karin M: The mammalian ultraviolet response is triggered by activation of Src. Cell 71: 1081-1091, 1992.
144. Syljuasen RG, Hong JH and McBride WH: Apoptosis and delayed expression of c-jun and c-fos after gamma irradiation of Jurkat T cells. Radiat Res 146: 276-282, 1996.
145. Chen YR, Meyer CF and Tan TH: Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem 271: 631-634, 1996.
146. Chae HP, Jarvis LJ and Uckun FM: Role of tyrosine phosphorylation in radiation-induced activation of c-jun protooncogene in human lymphohematopoietic precursor cells. Cancer Res 53: 447-451, 1993.
147. Gajate C, Alonso MT, Schimmang T and Mollinedo F: c-Fos is not essential for apoptosis. Biochem Biophys Res Commun 218: 267-272, 1996.
148. Eliot HE, Borner MM and Sinha BK: Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistance. Anticancer Res 15: 729-733, 1995.
149. Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S and Yalowich JC: Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol Pharmacol 46: 605-611, 1994.
150. Rubin E, Kharbanda S, Gunji H and Kufe D: Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide. Mol Pharmcol 39: 697-701, 1991.
151. Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J and Jarvis WD: Effect of 1-beta-D-arabino-furanosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Cell Growth Differ 7: 603-613, 1996.
152. Saleem A, Datta R, Yuan ZM, Kharbanda S and Kufe D: Involvement of stress activated protein kinase in the celluar response to 1-β-D-arabinofuranosylcytosine and other DNA-damaging agents. Cell Growth Differ 6: 1651-1658, 1995.
153. Gunji H, Kharbanda S and Kufe D: Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine. Cancer Res 51: 741-743, 1991.
154. Funato T, Yoshida E, Jiao L, Tone T, Kashani-Sabet M and Scanlon KJ: The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas. Adv Enzyme Regul 32: 195-209, 1992.
155. Rubin E, Kharbanda S, Gunji H, Weichselbaum R and Kufe D: cis-Diamminedichloroplatinum (II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway. Cancer Res 52: 878-882, 1992.
156. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75-79, 1996.
157. Sawai H, Okazaki T, Yamamoto H, Okano H, Takeda Y, Tashima M, Sawada H, Okuma M, Ishikura H, Umehara H, et al: Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 270: 27326-27331, 1995.
158. Reyes JG, Robayna IG, Delgado PS, Gonzalez IH, Aguiar JQ, Rosas FE, Fanjul LF and Galarreta CMR: c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells. J Biol Chem 271: 21375-21380, 1996.
159. Wilson DJ, Fortner KA, Lynch DH, Mattingly RR, Macara IG, Posada JA and Budd RC: JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol 26: 989-994, 1996.
160. Latinis KM and Koretzky GA: Fas ligation induces apoptosis and Jun kinase activity independently of CD45 and Lck in human T cells. Blood 87: 871-875, 1996.
161. Sanchez A, Alvarez AM, Benito M and Fabregat I: Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. J Biol Chem 271: 7416-7422, 1996.
162. Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, Isaacs JT and Davidson NE: Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 54: 5280-5283, 1994.
163. Walker PR, Kwast-Welfeld J, Gourdeau H, Leblanc J, Neugebauer W and Sikorska M: Relationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation, and API. Exp Cell Res 207: 142-151, 1993.
164. Gillardon F, Lenz C, Waschke KF, Krajewski S, Reed JC, Zimmermann M and Kuschinsky W: Altered expression of bcl-2, bcl-X, bax, and c-fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Mol Brain Res 40: 254-260, 1996.
165. Yu AC, Lee YL, Fu WY and Eng LF: Gene expression in astrocytes during and after ischemia. Prog Brain Res 105: 245-253, 1995.
166. Yamazaki T, Komuro I and Yazaki Y: Molecular mechanism of cardiac cellular hypertrophy by mechanical stress. J Mol Cell Cardiol 27: 133-140, 1995.
167. Cummings M: Increased c-fos expression associated with hyperthermia-induced apoptos of a Burkitt lymphoma cell line. Int J Radiat Biol 68: 687-692, 1995.
168. Troiano L, Monti D, Cossarizza A, Lovato E, Tropea F, Barbieri D, Morale MC, Gallo F, Marchetti B and Franceschi C: Involvement of CD45 in dexamethasone- and heat shock-induced apoptosis of rat thymocytes. Biochem Biophys Res Commun 214: 941-948, 1995.
169. Yao KS, Clayton M and O'Dwyer PJ: Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J Natl Cancer Inst 87: 117-122, 1995.
170. Li WC, Kuszak JR, Wang GM, Wu ZQ and Spector A: Calcimycin-induced lens epithelial cell apoptosis contributes to cataract formation. Exp Eye Res 61: 91-98, 1995.
171. Afshari CA, Bivins HM and Barrett JC: Utilization of a fos-lacZ plasmid to investigate the activation of c-fos during cellular senescence and okadaic acid-induced apoptosis. J Gerontol 49: B263-269, 1994.
172. Kaminska B, Lukasiuk K and Kaczmarek L: Seizures-evoked activation of transcription factors. Acta Neurobiol Exp 54: 65-72, 1994.
173. Kaminska B, Filipkowski RK, Zurkowska G, Lason W, Przewlocki R and Kaczmarek L: Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death. Eur J Neurosci 6: 1558-1566, 1994.
174. Filipkowski RK, Hetman M, Kaminska B and Kaczmarek L: DNA fragmentation in rat brain after intraperitoneal administration of kainate. Neuroreport 5: 1538-1540, 1994.
175. Freemerman AJ, Turner AJ, Birrer MJ, Szabo E, Valerie K and Grant S: Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C. Mol Pharmacol 49: 788-795, 1996.
176. Wang Q, Worland PJ, Clark JL, Carlson BA and Sausville EA: Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Cell Growth Differ 6: 927-936, 1995.
177. Young CY, Murtha PE and Zhang J: Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Oncol Res 6: 203-210, 1994.
178. Day ML, Zhao X, Wu S, Swanson PE and Humphrey PA: Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells. Cell Growth Differ 5: 735-741, 1994.